Summation and next steps

被引：0
|
作者：
Winter, HS
Grand, RJ
Ferry, GD
机构：
[1] Massachusetts Gen Hosp, Pediat GI Unit, Boston, MA 02114 USA
[2] Childrens Hosp, Boston, MA 02115 USA
[3] New England Med Ctr, Boston, MA 02111 USA
[4] Texas Childrens Hosp, Houston, TX 77030 USA
来源：
INFLAMMATORY BOWEL DISEASES | 1998年 / 4卷 / 02期
关键词：
biologic agents; Crohn's disease; methotrexate; pediatric population; ulcerative colitis;
D O I：
10.1097/00054725-199805000-00023
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [31] Optimizing Therapeutics: The Next Front in the War on Rheumatoid Arthritis
    Edison, J. D.
    Gilliland, W. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (04) : 561 - 566
  • [32] Next-Generation Endoscopy in Inflammatory Bowel Disease
    Zammarchi, Irene
    Santacroce, Giovanni
    Iacucci, Marietta
    DIAGNOSTICS, 2023, 13 (15)
  • [33] Taking immunogenicity assessment of therapeutic proteins to the next level
    Buettel, I. C.
    Chamberlain, P.
    Chowers, Y.
    Ehmann, F.
    Greinacher, A.
    Jefferis, R.
    Kramer, D.
    Kropshofer, H.
    Lloyd, P.
    Lubiniecki, A.
    Krause, R.
    Mire-Sluis, A.
    Platts-Mills, T.
    Ragheb, J. A.
    Reipert, B. M.
    Schellekens, H.
    Seitz, R.
    Stas, P.
    Subramanyam, M.
    Thorpe, R.
    Trouvin, J. -H.
    Weise, M.
    Windisch, J.
    Schneider, C. K.
    BIOLOGICALS, 2011, 39 (02) : 100 - 109
  • [34] Next generation of small molecules in inflammatory bowel disease
    Olivera, Pablo
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    GUT, 2017, 66 (02) : 199 - 209
  • [35] Osteosarcoma journey over two decades in India: Small steps, big changes
    Bajpai, Jyoti
    Chandrasekharan, Arun
    Simha, Vijai
    Mandal, Tanmoy
    Shah, Kajal
    Hingmare, Sachin
    Rangarajan, Bharath
    Shetty, Nishitha
    Vora, Tushar
    Ghosh, Jaya
    Rekhi, Bharat
    Banavali, Sripad
    Gupta, Sudeep
    PEDIATRIC BLOOD & CANCER, 2019, 66 (09)
  • [36] After interleukin-12p4O, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang, Zili
    Hinrichs, David J.
    Lu, Huiying
    Chen, Hong
    Zhong, Wenwei
    Kolls, Jay K.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (04) : 409 - 416
  • [37] Chronisch-entzündliche DarmerkrankungenNeue Therapien – was kommt in den nächsten Jahren?Inflammatory bowel diseasesNew treatments—what will come in the next few years?
    Sebastian Zeißig
    Der Gastroenterologe, 2019, 14 (6): : 462 - 469
  • [38] From Stool Transplants to Next-Generation Microbiota Therapeutics
    Petrof, Elaine O.
    Khoruts, Alexander
    GASTROENTEROLOGY, 2014, 146 (06) : 1573 - 1582
  • [39] Faecalibacterium prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement
    He, Xiaoya
    Zhao, Shuyang
    Li, Yan
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2021, 2021
  • [40] Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - What next?
    Block, M.
    Jorgensen, K. K.
    Oresland, T.
    Lindholm, E.
    Grzyb, K.
    Cvancarova, M.
    Vatn, M. H.
    Boberg, K. M.
    Borjesson, Borjesson L.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (05): : 421 - 430
12345